Events and Presentations

Recent Presentations

Canadian Liver Meeting 2021

  • Title: Higher seroproteciton rates (SPR) and higher anti-HBs concentrations in adults age 18+ achieved with 3-antigen hepatitis B vaccine (3A-HBV) compared to 1-antigen hepatitis B vaccine (1A-HBV): Results from the pivotal, double-blind, randomized Phase 3 study (PROTECT)
  • Date: May 4, 2021
  • Download Oral Presentation: PDF

2021 Annual Conference on Vaccinology Research (ACVR)

  • Title: Higher seroprotection rates (SPR) and anti-HBs titers achieved in adults with a 3-antigen hepatitis B vaccine (3A-HBV) compared to a 1-antigen hepatitis B vaccine (1A-HBV): Results of the PROTECT study
  • Date: April 27, 2021
  • Download Presentation: PDF

2020 Annual Meeting of the European Association for the Study of the Liver (EASL)

  • Title: High HBsAb Titers Consistent Across 3 Lots of the Tri-Antigenic Hepatitis B (HBV) Vaccine, Sci-B-Vac®: Results from the Second Pivotal Phase 3 Double-Blind, Randomized Controlled Trial Designed to Assess the Lot-to-Lot Consistency of Sci-B-Vac® in Adults (CONSTANT)
  • Date: August 31, 2020
  • Download Presentation: PDF
  • Video: Watch

Recent & Upcoming Events

H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

  • Date: October 13, 2021
  • Time: 4-4:30 PM ET
  • Webcast: Watch

VBI’s eVLP COVID-19 Vaccine Candidate: Initial Positive Phase 1 Data

  • Date: June 29, 2021
  • Webcast: Replay
  • Download Presentation: PDF

Hepatitis B Portfolio Analyst-Led Fireside Chat

Hosted by Raymond James

  • Date: December 8, 2020
  • Webcast: Replay
  • Download Presentation: PDF

VBI-2601 (BRII-179): Interim Phase 1b/2a Data

  • Date: November 18, 2020
  • Webcast: Replay
  • Download Presentation: PDF

Preclinical Coronavirus Program Data

  • Date: August 26, 2020
  • Webcast: Replay
  • Download Presentation: PDF
Go top